Neurologic Manifestations
Clinical signs and symptoms caused by nervous system injury or dysfunction.
Subtype terms (25)
More specific conditions that are subtypes of Neurologic Manifestations in the MeSH hierarchy.
- Bilateral Vestibulopathy
- Cerebral Cortical Thinning
- Cerebrospinal Fluid Leak
7 drugs (6 approved, 1 experimental)
- Decerebrate State
- Dyskinesias
23 drugs (15 approved, 8 experimental)
- Gait Disorders, Neurologic
13 drugs approved
- Meningism
- Neurobehavioral Manifestations
17 drugs (13 approved, 4 experimental)
- Neurogenic Inflammation
4 drugs (1 approved, 3 experimental)
- Neuromuscular Manifestations
4 drugs (3 approved, 1 experimental)
- Orthostatic Intolerance
39 drugs (35 approved, 4 experimental)
- Pain
757 drugs (377 approved, 380 experimental)
- Paralysis
18 drugs (12 approved, 6 experimental)
- Paresis
11 drugs (10 approved, 1 experimental)
- Pseudobulbar Affect
- Psychophysiologic Disorders
97 drugs (70 approved, 27 experimental)
- Pupil Disorders
3 drugs approved
- Reflex, Abnormal
2 drugs approved
- Seizures
94 drugs (68 approved, 26 experimental)
- Sensation Disorders
4 drugs (2 approved, 2 experimental)
- Sleep Wake Disorders
99 drugs (72 approved, 27 experimental)
- Susac Syndrome
- Urinary Bladder, Neurogenic
34 drugs (23 approved, 11 experimental)
- Vertigo
42 drugs (30 approved, 12 experimental)
- Voice Disorders
9 drugs (6 approved, 3 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (1)
Phase 2 trials (6)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (4)